Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 152.90 Delayed Data As of Aug 23 |  -2.09 / -1.35%Today’s Change | 95.14 Today|||52-Week Range 157.41 | +35.69% Year-to-Date |
| Why ABIOMED (ABMD) Could Be Positioned for a Surge Aug 10 / Zacks.com - Paid Partner Content |
| Previous close | 154.99 |
| Today’s open | 154.76 |
| Day’s range | 152.75 - 154.93 |
| Volume | 215,339 |
| Average volume (3 months) | 308,711 |
| Market cap | $6.8B |
| Dividend yield | -- |
| Earnings growth (last year) | +37.65% |
| Earnings growth (this year) | +84.81% |
| Earnings growth (next 5 years) | +36.00% |
| Revenue growth (last year) | +35.13% |
| P/E ratio | 89.9 |
| Price/Sales | 12.56 |
| Price/Book | 14.97 |
| Today’s change | Today’s % change | |
|---|---|---|
| DXCMDexCom Inc | -0.72 | -0.95% |
| WSTWest Pharmaceutical ... | -1.33 | -1.55% |
| MASIMasimo Corp | -2.16 | -2.49% |
| TFXTeleflex Inc | -5.37 | -2.52% |
| Next reporting date | November 2, 2017 |
| EPS forecast (this quarter) | $0.38 |
| Annual revenue (last year) | $445.3M |
| Annual profit (last year) | $52.1M |
| Net profit margin | 11.70% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael R. Minogue |
Chief Operating Officer David M. Weber |
Corporate headquarters Danvers, Massachusetts |
